Matrixx to move HQ
SKILLMAN, N.J. — With former Wyeth executive Dennis O’Donnell at the helm, Matrixx Initiatives is making a headquarter transition from Phoenix to here in New Jersey, according to a story published in the Arizona Republic earlier this week.
The company, however, will maintain offices in Arizona, the report stated.
FDA seizes probiotic products from UAS Labs
SILVER SPRING, Md. — The Food and Drug Administration reported Tuesday that U.S. marshals seized probiotic products from UAS Labs that were being marketed as drugs.
The FDA said UAS Labs products, including DDS Acidophilus, DDS Plus, Probioplus DDS, DDS Junior and Cran-Gyn DDS, claimed they could treat or prevent colds, flu, respiratory infections, urinary tract infections, yeast infections, ulcers and high cholesterol. These claims violate the Federal Food, Drug, and Cosmetic Act, which restricts the use of disease claims to approved — or otherwise legally marketed — drugs.
The company, based in Eden Prairie, Minn., markets the products in the United States and internationally.
HDMA announces 2011 DIANA winners
PHOENIX — The Healthcare Distribution Management Association on Monday awarded eight leading pharmaceutical and consumer product manufacturers through the presentation of its annual Distribution Industry Awards for Notable Achievements in health care.
“The 2011 DIANA honorees set the standard for excellence in the healthcare supply chain, introducing innovative new products to the marketplace and forging lasting partnerships with their peers in the healthcare distribution industry,” stated HDMA president and CEO John Gray. “These winning companies lead the way with their continuing commitment to creativity and collaboration, and we congratulate them on their achievements.”
The 2011 DIANA winners are:
Best New Pharmaceutical Product Introduction or Product Promotion Awards — Branded Pharmaceutical Products: Boehringer Ingelheim Pharmaceuticals for Pradaxa; Generic Pharmaceutical Products: Sandoz for Enoxaparin;
Best Overall Manufacturer Awards — Consumer product manufacturer with sales to healthcare distributors of less than $10 million: Omron Healthcare;
Consumer product manufacturer with sales to healthcare distributors of more than $10 million: Roche Diagnostics;
Generic product manufacturer with sales to healthcare distributors of less than $100 million: Lupin Pharmaceuticals;
Generic product manufacturer with sales to healthcare distributors of more than $100 million: Watson Pharmaceuticals;
Branded pharmaceutical product manufacturer with sales to healthcare distributors of less than $300 mllion: Upsher-Smith Labs; and
Branded pharmaceutical product manufacturer with sales to healthcare distributors of more than $300 million: Takeda Pharmaceuticals North America.
HDMA has awarded the DIANA to manufacturers for developing innovative new product introductions and promotions for the healthcare distribution industry. The awards also recognize companies that continually foster strong trading partner relationships with the Association’s primary distributor members by creating exceptional business practices that advance trade relations and benefit the entire healthcare supply chain.
Award winners were selected by HDMA distributor members. For the Best Overall Manufacturer awards, winners were chosen on criteria ranging from developing collaborative trading partner relationships to creating marketing programs that benefit the supply chain and commitment to excellence. Among other criteria, the Best New Product Introduction or Promotion winners were judged on their ability to create innovative marketing programs, their level of market performance, promotional support and operational excellence.
The winners were announced at the association’s 2011 Business & Leadership Conference.